Jump Trading’s Minerva Neurosciences NERV Stock Holding History

Jump Trading’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,413	Closed	-$142K	–	353
2018 Q3	$142K	Buy	+1,413	New	+$106K	0.01%	351

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

IVAV

Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Jump Trading's NERV Position: Q4 2018 in Review

Jump Trading sold out of Minerva Neurosciences (NERV) in Q4 2018, closing a stake of 1,413 shares — an estimated $142K sold.

Jump Trading first reported a position in NERV in Q3 2018 and held it in 1 quarter. The position peaked at $142K in Q3 2018. 84 funds tracked by Wall St. Rank hold NERV as of Q4 2018.

Jump Trading reported no remaining Minerva Neurosciences position as of Q4 2018 after selling out during the quarter.
Jump Trading sold 1,413 Minerva Neurosciences shares in Q4 2018, an estimated $142K.
Jump Trading first reported a position in Minerva Neurosciences in Q3 2018 and held it in 1 quarter.
Jump Trading's Minerva Neurosciences position peaked at $142K in Q3 2018.
84 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2018.

Based on Jump Trading's 13F filing for Q4 2018, filed 14 Feb 2019.